Serum Prestin After Ototoxin Exposure Is Not Dependent on Outer Hair Cell Loss

  • 0Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, University of Connecticut School of Medicine, Farmington, Connecticut.

Summary

This summary is machine-generated.

Cyclodextrin (CDX) causes a serum prestin increase independent of outer hair cell (OHC) loss. This N-glycosylated prestin burst may serve as an early ototoxicity biomarker for intervention.

Area Of Science

  • Ototoxicity research
  • Biomarker discovery
  • Auditory neuroscience

Background

  • Serum prestin is a potential biomarker for ototoxicity.
  • Previous studies introduced a cyclodextrin (CDX) ototoxicity model.
  • Further characterization of serum prestin in this model is needed.

Purpose Of The Study

  • To investigate the relationship between CDX-induced serum prestin changes and outer hair cell (OHC) loss.
  • To characterize the nature of the serum prestin burst.
  • To evaluate serum prestin as an early biomarker for ototoxicity.

Main Methods

  • Guinea pigs were administered varying doses of CDX (750, 3,000, 4,000 mg/kg).
  • Serum prestin levels were quantified using automated Western analysis over 15 weeks.
  • Hair cell counts were performed to assess OHC damage.

Main Results

  • All CDX doses induced an N-glycosylated ~134-kDa prestin burst.
  • Significant OHC loss was observed only at higher CDX doses (3,000 and 4,000 mg/kg).
  • Serum prestin returned to baseline levels and remained stable even with OHC loss.

Conclusions

  • The CDX-induced ~134-kDa prestin burst is a post-translationally modified, N-glycosylated form of prestin.
  • Serum prestin is a promising biomarker for ototoxicity, as its elevation is not contingent on OHC loss.
  • This finding allows for early detection and intervention of ototoxicity.